Stocktoria
4D Molecular Therapeutics, Inc. FDMT
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-12-11
4D Molecular Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 4,896,897 | $102.8M |
| RENAISSANCE TECHNOLOGIES LLC | 578,265 | $5.4M |
| CITADEL ADVISORS LLC | 317,096 | $3.0M |
| TWO SIGMA INVESTMENTS, LP | 124,317 | $1.2M |
| AQR CAPITAL MANAGEMENT LLC | 45,777 | $426,183 |
| D. E. Shaw & Co., Inc. | 24,030 | $223,719 |
Source: SEC EDGAR filings · CIK 0001650648 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.